Biotech / Medtech Archives | citybizSciencenews

Polaryx Therapeutics Names Will Charlton CMO Ahead of Phase 2 SOTERIA Trial

Tuesday, September 1, 2026Win WarfieldView original

Polaryx Therapeutics, Inc. (Nasdaq: PLYX) has appointed Will Charlton, M.D., M.A.S., as chief medical officer, strengthening its clinical leadership as... Read More

The post Polaryx Therapeutics Names Will Charlton CMO Ahead of Phase 2 SOTERIA Trial appeared first on citybiz.